Macrobid shortage update: What patients need to know in 2026

Macrobid Shortage Update: February 2026

The Macrobid (Nitrofurantoin) shortage continues to affect patients across the United States in early 2026. If you rely on this antibiotic for UTI treatment or prevention, here's everything you need to know about the current situation.

Current Status of the Macrobid Shortage

As of February 2026, Macrobid and generic Nitrofurantoin remain in limited supply at many pharmacies nationwide. The shortage is not uniform — some pharmacies have adequate stock while others have been out for weeks. The situation varies by region, pharmacy chain, and formulation.

The FDA's Drug Shortage Database continues to list Nitrofurantoin as a medication with supply concerns. Several generic manufacturers have reported intermittent production and shipping delays.

What's Causing the Shortage?

The current shortage is driven by multiple overlapping factors:

Manufacturing Issues

Several Nitrofurantoin manufacturers have faced production challenges, including equipment maintenance, facility upgrades, and FDA compliance inspections. With only a handful of companies producing the drug in the US market, any single disruption has an outsized effect on supply.

Raw Material Constraints

The active pharmaceutical ingredient (API) for Nitrofurantoin is sourced from a limited number of global suppliers. Ongoing supply chain pressures — including shipping delays and increased regulatory requirements — have slowed the flow of raw materials to manufacturers.

Rising Demand

UTI prescribing has shifted in recent years. As medical guidelines increasingly recommend against fluoroquinolones (like Ciprofloxacin) for uncomplicated UTIs due to serious side effects, demand for first-line agents like Nitrofurantoin and Trimethoprim-sulfamethoxazole has increased. For more background, see our article on why Macrobid is so hard to find.

Which Formulations Are Affected?

The shortage primarily affects:

• Macrobid (Nitrofurantoin monohydrate/macrocrystals) 100 mg capsules — the most commonly prescribed form
• Macrodantin (Nitrofurantoin macrocrystals) 25 mg and 100 mg capsules — an older formulation
• Nitrofurantoin oral suspension — used for patients who can't swallow capsules

Availability varies by formulation. In some areas, one version may be available even when others are not. Ask your pharmacist about all available forms.

When Will the Shortage End?

There's no definitive end date for the Macrobid shortage. The FDA is working with manufacturers to increase production, and some companies have reported progress in resolving their supply chain issues. Industry analysts suggest that availability may begin to stabilize by mid-to-late 2026, but this is not guaranteed.

Drug shortages can be unpredictable. New disruptions — a factory shutdown, a regulatory issue, or a spike in demand — can extend a shortage beyond initial projections.

What Should Patients Do Right Now?

1. Don't Stockpile

It's tempting to ask for extra refills, but hoarding medications makes the shortage worse for everyone. Only fill the amount your doctor prescribes.

2. Use MedFinder to Check Availability

MedFinder helps you find pharmacies that currently have Macrobid in stock. Check it regularly, as stock levels change daily. See our detailed guide on how to find Macrobid in stock near you.

3. Consider All Pharmacy Types

Don't just check your regular pharmacy. Try independent pharmacies, grocery store pharmacies (Kroger, H-E-B, Publix), big-box stores (Costco, Walmart), and mail-order pharmacies.

4. Ask About Alternatives

If Macrobid is unavailable, talk to your doctor about alternative antibiotics for UTIs. Options like Bactrim, Fosfomycin, and Cephalexin may be more readily available.

5. Don't Delay Treatment

UTIs should be treated promptly. If you can't find Macrobid, contact your doctor the same day. An untreated UTI can progress to a kidney infection, which is much more serious and may require hospitalization.

What About Patients Who Take Macrobid for Prevention?

Some patients take low-dose Nitrofurantoin (50-100 mg) daily as UTI prophylaxis. If you're in this group and can't find your medication:

• Talk to your doctor about whether you can temporarily pause prophylaxis
• Ask about alternative prophylactic strategies
• Consider behavioral measures (hydration, post-intercourse voiding, cranberry products) while waiting for supply to improve

Do not stop taking a prescribed medication without talking to your doctor first.

How to Stay Updated

Bookmark this page — we update it as new information becomes available. You can also check these resources:

• FDA Drug Shortage Database
• ASHP Drug Shortage Resource Center
• MedFinder for real-time pharmacy stock checks

Key Takeaways

• The Macrobid shortage continues in early 2026 due to manufacturing, supply chain, and demand issues.
• Availability varies by pharmacy and region — check multiple sources.
• Use MedFinder to find pharmacies with Macrobid in stock.
• Don't delay UTI treatment. If you can't find Macrobid, ask your doctor for an alternative antibiotic immediately.
• The shortage may improve by mid-to-late 2026, but there's no guaranteed timeline.